Cargando…
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes
BACKGROUND: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single nucleotide polymorphisms (SNPs)) associated with risk of developing breast cancer. A score based on the combined effect of the 94 risk alleles can be calculated to measure the global risk of breast...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568360/ https://www.ncbi.nlm.nih.gov/pubmed/28830573 http://dx.doi.org/10.1186/s13058-017-0888-4 |
_version_ | 1783258847555616768 |
---|---|
author | Curtit, Elsa Pivot, Xavier Henriques, Julie Paget-Bailly, Sophie Fumoleau, Pierre Rios, Maria Bonnefoi, Hervé Bachelot, Thomas Soulié, Patrick Jouannaud, Christelle Bourgeois, Hugues Petit, Thierry Tennevet, Isabelle Assouline, David Mathieu, Marie-Christine Jacquin, Jean-Philippe Lavau-Denes, Sandrine Darut-Jouve, Ariane Ferrero, Jean-Marc Tarpin, Carole Lévy, Christelle Delecroix, Valérie Trillet-Lenoir, Véronique Cojocarasu, Oana Meunier, Jérôme Pierga, Jean-Yves Kerbrat, Pierre Faure-Mercier, Céline Blanché, Hélène Sahbatou, Mourad Boland, Anne Bacq, Delphine Besse, Céline Thomas, Gilles Deleuze, Jean-François Pauporté, Iris Romieu, Gilles Cox, David G. |
author_facet | Curtit, Elsa Pivot, Xavier Henriques, Julie Paget-Bailly, Sophie Fumoleau, Pierre Rios, Maria Bonnefoi, Hervé Bachelot, Thomas Soulié, Patrick Jouannaud, Christelle Bourgeois, Hugues Petit, Thierry Tennevet, Isabelle Assouline, David Mathieu, Marie-Christine Jacquin, Jean-Philippe Lavau-Denes, Sandrine Darut-Jouve, Ariane Ferrero, Jean-Marc Tarpin, Carole Lévy, Christelle Delecroix, Valérie Trillet-Lenoir, Véronique Cojocarasu, Oana Meunier, Jérôme Pierga, Jean-Yves Kerbrat, Pierre Faure-Mercier, Céline Blanché, Hélène Sahbatou, Mourad Boland, Anne Bacq, Delphine Besse, Céline Thomas, Gilles Deleuze, Jean-François Pauporté, Iris Romieu, Gilles Cox, David G. |
author_sort | Curtit, Elsa |
collection | PubMed |
description | BACKGROUND: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single nucleotide polymorphisms (SNPs)) associated with risk of developing breast cancer. A score based on the combined effect of the 94 risk alleles can be calculated to measure the global risk of breast cancer. We aimed to test the hypothesis that the 94-SNP-based risk score is associated with clinico-pathological characteristics, breast cancer subtypes and outcomes in early breast cancer. METHODS: A 94-SNP risk score was calculated in 8703 patients in the PHARE and SIGNAL prospective case cohorts. This score is the total number of inherited risk alleles based on 94 selected SNPs. Clinical data and outcomes were prospectively registered. Genotyping was obtained from a GWAS. RESULTS: The median 94-SNP risk score in 8703 patients with early breast cancer was 77.5 (range: 58.1–97.6). The risk score was not associated with usual prognostic and predictive factors (age; tumor, node, metastasis (TNM) status; Scarff-Bloom-Richardson grade; inflammatory features; estrogen receptor status; progesterone receptor status; human epidermal growth factor receptor 2 (HER2) status) and did not correlate with breast cancer subtypes. The 94-SNP risk score did not predict outcomes represented by overall survival or disease-free survival. CONCLUSIONS: In a prospective case cohort of 8703 patients, a risk score based on 94 SNPs was not associated with breast cancer characteristics, cancer subtypes, or patients’ outcomes. If we hypothesize that prognosis and subtypes of breast cancer are determined by constitutional genetic factors, our results suggest that a score based on breast cancer risk-associated SNPs is not associated with prognosis. TRIAL REGISTRATION: PHARE cohort: NCT00381901, Sept. 26, 2006 – SIGNAL cohort: INCa RECF1098, Jan. 28, 2009 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-017-0888-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5568360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-55683602017-08-29 Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes Curtit, Elsa Pivot, Xavier Henriques, Julie Paget-Bailly, Sophie Fumoleau, Pierre Rios, Maria Bonnefoi, Hervé Bachelot, Thomas Soulié, Patrick Jouannaud, Christelle Bourgeois, Hugues Petit, Thierry Tennevet, Isabelle Assouline, David Mathieu, Marie-Christine Jacquin, Jean-Philippe Lavau-Denes, Sandrine Darut-Jouve, Ariane Ferrero, Jean-Marc Tarpin, Carole Lévy, Christelle Delecroix, Valérie Trillet-Lenoir, Véronique Cojocarasu, Oana Meunier, Jérôme Pierga, Jean-Yves Kerbrat, Pierre Faure-Mercier, Céline Blanché, Hélène Sahbatou, Mourad Boland, Anne Bacq, Delphine Besse, Céline Thomas, Gilles Deleuze, Jean-François Pauporté, Iris Romieu, Gilles Cox, David G. Breast Cancer Res Research Article BACKGROUND: Genome-wide association studies (GWAS) have to date identified 94 genetic variants (single nucleotide polymorphisms (SNPs)) associated with risk of developing breast cancer. A score based on the combined effect of the 94 risk alleles can be calculated to measure the global risk of breast cancer. We aimed to test the hypothesis that the 94-SNP-based risk score is associated with clinico-pathological characteristics, breast cancer subtypes and outcomes in early breast cancer. METHODS: A 94-SNP risk score was calculated in 8703 patients in the PHARE and SIGNAL prospective case cohorts. This score is the total number of inherited risk alleles based on 94 selected SNPs. Clinical data and outcomes were prospectively registered. Genotyping was obtained from a GWAS. RESULTS: The median 94-SNP risk score in 8703 patients with early breast cancer was 77.5 (range: 58.1–97.6). The risk score was not associated with usual prognostic and predictive factors (age; tumor, node, metastasis (TNM) status; Scarff-Bloom-Richardson grade; inflammatory features; estrogen receptor status; progesterone receptor status; human epidermal growth factor receptor 2 (HER2) status) and did not correlate with breast cancer subtypes. The 94-SNP risk score did not predict outcomes represented by overall survival or disease-free survival. CONCLUSIONS: In a prospective case cohort of 8703 patients, a risk score based on 94 SNPs was not associated with breast cancer characteristics, cancer subtypes, or patients’ outcomes. If we hypothesize that prognosis and subtypes of breast cancer are determined by constitutional genetic factors, our results suggest that a score based on breast cancer risk-associated SNPs is not associated with prognosis. TRIAL REGISTRATION: PHARE cohort: NCT00381901, Sept. 26, 2006 – SIGNAL cohort: INCa RECF1098, Jan. 28, 2009 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13058-017-0888-4) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-22 2017 /pmc/articles/PMC5568360/ /pubmed/28830573 http://dx.doi.org/10.1186/s13058-017-0888-4 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Curtit, Elsa Pivot, Xavier Henriques, Julie Paget-Bailly, Sophie Fumoleau, Pierre Rios, Maria Bonnefoi, Hervé Bachelot, Thomas Soulié, Patrick Jouannaud, Christelle Bourgeois, Hugues Petit, Thierry Tennevet, Isabelle Assouline, David Mathieu, Marie-Christine Jacquin, Jean-Philippe Lavau-Denes, Sandrine Darut-Jouve, Ariane Ferrero, Jean-Marc Tarpin, Carole Lévy, Christelle Delecroix, Valérie Trillet-Lenoir, Véronique Cojocarasu, Oana Meunier, Jérôme Pierga, Jean-Yves Kerbrat, Pierre Faure-Mercier, Céline Blanché, Hélène Sahbatou, Mourad Boland, Anne Bacq, Delphine Besse, Céline Thomas, Gilles Deleuze, Jean-François Pauporté, Iris Romieu, Gilles Cox, David G. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes |
title | Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes |
title_full | Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes |
title_fullStr | Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes |
title_full_unstemmed | Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes |
title_short | Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes |
title_sort | assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the signal/phare prospective cohort: no correlation with clinico-pathological characteristics and outcomes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568360/ https://www.ncbi.nlm.nih.gov/pubmed/28830573 http://dx.doi.org/10.1186/s13058-017-0888-4 |
work_keys_str_mv | AT curtitelsa assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT pivotxavier assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT henriquesjulie assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT pagetbaillysophie assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT fumoleaupierre assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT riosmaria assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT bonnefoiherve assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT bachelotthomas assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT souliepatrick assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT jouannaudchristelle assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT bourgeoishugues assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT petitthierry assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT tennevetisabelle assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT assoulinedavid assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT mathieumariechristine assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT jacquinjeanphilippe assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT lavaudenessandrine assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT darutjouveariane assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT ferrerojeanmarc assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT tarpincarole assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT levychristelle assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT delecroixvalerie assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT trilletlenoirveronique assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT cojocarasuoana assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT meunierjerome assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT piergajeanyves assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT kerbratpierre assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT fauremercierceline assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT blanchehelene assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT sahbatoumourad assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT bolandanne assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT bacqdelphine assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT besseceline assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT thomasgilles assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT deleuzejeanfrancois assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT pauporteiris assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT romieugilles assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes AT coxdavidg assessmentoftheprognosticroleofa94singlenucleotidepolymorphismsriskscoreinearlybreastcancerinthesignalphareprospectivecohortnocorrelationwithclinicopathologicalcharacteristicsandoutcomes |